                         SEQUENCE LISTING

<110>  Universit degli Studi di Trieste
 
<120>  GP APTAMER OLIGONUCLEOTIDES AND USE THEREOF AS ANTITUMOR AGENTS

<130>  10593PTWO

<150>  PD2010A000272
<151>  2010-09-13

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  75
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Cytotoxic oligonucleotide sequence

<400>  1
tgtttgtttg tttgtttgtt tgtttgtttg tttgtttgtt tgtttgtttg tttgtttgtt       60

tgtttgtttg tttgt                                                        75


<210>  2
<211>  27
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Cytotoxic oligonucleotide sequence

<400>  2
tgtttgtttg tttgtttgtt tgtttgt                                           27


<210>  3
<211>  51
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Cytotoxic oligonucleotide sequence

<400>  3
tgtttgtttg tttgtttgtt tgtttgtttg tttgtttgtt tgtttgtttg t                51


<210>  4
<211>  75
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Cytotoxic oligonucleotide sequence

<400>  4
tctttctttc tttctttctt tctttctttc tttctttctt tctttctttc tttctttctt       60

tctttctttc tttct                                                        75


<210>  5
<211>  27
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Cytotoxic oligonucleotide sequence

<400>  5
tctttctttc tttctttctt tctttct                                           27


<210>  6
<211>  51
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Cytotoxic oligonucleotide sequence

<400>  6
tctttctttc tttctttctt tctttctttc tttctttctt tctttctttc t                51


